Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Walker

Showing results (81-90 of 218) with videos related to

Pageof 22
Sort By:
European Journal of Endocrinology|March 5, 2005
Is there a gender difference in the associations of birthweight and adult hypothalamic-pituitary-adrenal axis activity?Rebecca M Reynolds, Brian R Walker, Holly E Syddall, et al.
BMJ (Clinical Research Ed.)|April 12, 2019
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort studyLi Wei, Edward Chia-Cheng Lai, Yea-Huei Kao-Yang, et al.
Plos One|January 11, 2011
Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migrationJames J Logie, Sadaf Ali, Kathryn M Marshall, et al.
The Journal of Endocrinology|September 21, 2016
Metabolic dysfunction in female mice with disruption of 5α-reductase 1Dawn E W Livingstone, Emma M Di Rollo, Tracy C-S Mak, et al.
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activityEva Rask, Brian R Walker, Stefan Söderberg, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 15, 2010
Partial deficiency or short-term inhibition of 11beta-hydroxysteroid dehydrogenase type 1 improves cognitive function in aging miceKaren Sooy, Scott P Webster, June Noble, et al.
The Journal of Clinical Endocrinology and Metabolism|December 20, 2019
GDF15 Is Elevated in Conditions of Glucocorticoid Deficiency and Is Modulated by Glucocorticoid ReplacementAudrey Melvin, Dimitrios Chantzichristos, Catriona J Kyle, et al.
The Journal of Clinical Endocrinology and Metabolism|March 29, 2019
Higher Insulin Resistance and Adiposity in Postmenopausal Women With Breast Cancer Treated With Aromatase InhibitorsFraser W Gibb, J Michael Dixon, Catriona Clarke, et al.
European Journal of Endocrinology|February 7, 2004
Influence of short-term dietary weight loss on cortisol secretion and metabolism in obese menAlexandra M Johnstone, Peter Faber, Ruth Andrew, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 2007
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in menDeborah J Wake, Roland H Stimson, Garry D Tan, et al.
Pageof 22

Showing results (81-90 of 218) with videos related to

Sort By:
Pageof 22
European Journal of Endocrinology|March 5, 2005
Is there a gender difference in the associations of birthweight and adult hypothalamic-pituitary-adrenal axis activity?Rebecca M Reynolds, Brian R Walker, Holly E Syddall, et al.
BMJ (Clinical Research Ed.)|April 12, 2019
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort studyLi Wei, Edward Chia-Cheng Lai, Yea-Huei Kao-Yang, et al.
Plos One|January 11, 2011
Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migrationJames J Logie, Sadaf Ali, Kathryn M Marshall, et al.
The Journal of Endocrinology|September 21, 2016
Metabolic dysfunction in female mice with disruption of 5α-reductase 1Dawn E W Livingstone, Emma M Di Rollo, Tracy C-S Mak, et al.
The Journal of Clinical Endocrinology and Metabolism|July 11, 2002
Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activityEva Rask, Brian R Walker, Stefan Söderberg, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 15, 2010
Partial deficiency or short-term inhibition of 11beta-hydroxysteroid dehydrogenase type 1 improves cognitive function in aging miceKaren Sooy, Scott P Webster, June Noble, et al.
The Journal of Clinical Endocrinology and Metabolism|December 20, 2019
GDF15 Is Elevated in Conditions of Glucocorticoid Deficiency and Is Modulated by Glucocorticoid ReplacementAudrey Melvin, Dimitrios Chantzichristos, Catriona J Kyle, et al.
The Journal of Clinical Endocrinology and Metabolism|March 29, 2019
Higher Insulin Resistance and Adiposity in Postmenopausal Women With Breast Cancer Treated With Aromatase InhibitorsFraser W Gibb, J Michael Dixon, Catriona Clarke, et al.
European Journal of Endocrinology|February 7, 2004
Influence of short-term dietary weight loss on cortisol secretion and metabolism in obese menAlexandra M Johnstone, Peter Faber, Ruth Andrew, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 2007
Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in menDeborah J Wake, Roland H Stimson, Garry D Tan, et al.
Pageof 22